S-1/A: Trans American Aquaculture Files Amendment for $10 Million Stock Resale by GHS Investments

Sentiment:

S-1/A (Registration Statement Amendment)


Trans American Aquaculture, Inc. has filed a pre-effective amendment to its Form S-1 registration statement, covering the offer and resale of up to 533,695,874 shares of common stock by GHS Investments LLC, potentially representing a significant portion of the company's outstanding shares and public float.

Capital raiseThe document details an Equity Financing Agreement (EFA) with GHS Investments LLC, where GHS may purchase up to $10,000,000 in shares of the company's common stock over 24 months.The purchase price per share will be 80% of the lowest traded price of the common stock during the ten consecutive trading days preceding the date of the Put notice.The company has also entered into Securities Purchase Agreements with GHS, involving the sale of Series D Preferred Stock and warrants to purchase common stock.

Summary

  • Trans American Aquaculture, Inc. has filed a pre-effective Amendment No. 3 to its Form S-1 registration statement.
  • The registration statement pertains to the offer and resale of up to 533,695,874 shares of common stock by GHS Investments LLC.
  • These shares may be purchased by GHS Investments LLC pursuant to an Equity Financing Agreement (EFA) dated January 20, 2023.
  • If issued presently, the additional 533,695,874 shares of common stock registered for resale by the Selling Security Holder under the EFA, all of which have yet to be issued, would represent 27.97% of our issued and outstanding shares of common stock as of January 25, 2024.
  • The additional shares registered for resale would represent approximately 33% of the Company's public float after issuance.
  • The Company will not receive any proceeds from the sale of shares by GHS.
  • GHS may offer the shares from time to time through public or private transactions at prevailing market prices or at privately negotiated prices.
  • The Company's common stock is currently quoted on the OTC Markets under the symbol GRPS, with the last reported sale price on January 22, 2024, at $0.0027.
  • The Company has issued Series B, Series C, and Series D Preferred Stock with different voting rights than the common stock, potentially giving preferred stockholders control over corporate actions.
  • Investing in the Company's common stock involves a high degree of risk, as detailed in the Risk Factors section of the prospectus.
  • The Company's executive offices are located in Dallas, Texas, and its website is www.transamaqua.com.

Sentiment

Score: 4

Explanation: The document is largely neutral, providing factual information about the share offering. However, the emphasis on risk factors and the lack of positive financial projections temper the sentiment.

Positives

  • The Equity Financing Agreement with GHS Investments provides a potential source of capital for the Company.
  • The Company's products are eco-friendly in that the farm does not discharge into the environment.
  • The Company's products are safe in that they are 100% chemical and antibiotic free.
  • The Company has and will continue to utilize superior genetic linage broodstock for cultivation of own post larvae in our onsite maturation and hatchery.

Negatives

  • The Company will not receive any proceeds from the resale of shares by GHS Investments.
  • The potential issuance of a large number of shares could dilute existing shareholders' equity.
  • The Company's common stock is quoted on the OTC Markets, which may have limited liquidity.
  • The Company has outstanding preferred stock with significant voting rights, potentially diluting the influence of common stockholders.
  • The document emphasizes that investing in the company's common stock involves a high degree of risk.

Risks

  • The potential issuance of a large number of shares could dilute existing shareholders' equity.
  • The Company's common stock is quoted on the OTC Markets, which may have limited liquidity.
  • The Company has outstanding preferred stock with significant voting rights, potentially diluting the influence of common stockholders.
  • The document emphasizes that investing in the company's common stock involves a high degree of risk.
  • The Company needs to continue as a going concern if our business is to succeed.
  • The Company is currently in default of secured debt, which is currently in default, and, if the lender forecloses, you may lose all of your investment and our business would fail.
  • The Company is currently in a legal dispute with Kings Aqua Farm LLC and, if we were to lose, it would have a negative impact on our business.

Future Outlook

The document does not provide specific forward-looking statements regarding the company's future financial performance or operational milestones, but it does mention the potential for GHS to purchase up to $10,000,000 in shares of common stock over the course of 24 months after the registration statement is effective.

Industry Context

The document does not provide specific details about the broader aquaculture industry trends or competitive landscape beyond mentioning that the company specializes in sustainably raised farmed shrimp.

Stakeholder Impact

  • Existing shareholders may experience dilution due to the potential issuance of a large number of shares.
  • The market price of the common stock could be affected by the offering and resale of shares by GHS Investments LLC.
  • The Company's ability to execute its business plan and raise additional capital could be influenced by the success of the offering.

Next Steps

  • The Registration Statement needs to be declared effective by the SEC.
  • GHS Investments LLC may then offer and sell the registered shares of common stock.
  • The Company may use the proceeds from the Puts for general corporate and working capital purposes and acquisitions or assets, businesses or operations or for purposes our Board of Directors deems to be in the best interests of the Company.

Key Dates

DateDescription
January 20, 2023Date of the Equity Financing Agreement (EFA) between Trans American Aquaculture, Inc. and GHS Investments LLC.
January 22, 2024Date of the last reported sale price of the Company's Common Stock on the OTC Markets at $0.0027.
January 25, 2024Date of the prospectus.

Keywords

common stock, GHS Investments, equity financing, aquaculture, shares, resale, preferred stock, OTC Markets, risk factors, Trans American Aquaculture

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.